These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24375726)

  • 1. Neurovascular protection of cilostazol in stroke-prone spontaneous hypertensive rats associated with angiogenesis and pericyte proliferation.
    Omote Y; Deguchi K; Kono S; Liu N; Liu W; Kurata T; Yamashita T; Ikeda Y; Abe K
    J Neurosci Res; 2014 Mar; 92(3):369-74. PubMed ID: 24375726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological improvement in stroke-prone spontaneous hypertensive rats related to the pleiotropic effect of cilostazol.
    Omote Y; Deguchi K; Tian F; Kawai H; Kurata T; Yamashita T; Ohta Y; Abe K
    Stroke; 2012 Jun; 43(6):1639-46. PubMed ID: 22492522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats.
    Oyama N; Yagita Y; Kawamura M; Sugiyama Y; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K
    Stroke; 2011 Sep; 42(9):2571-7. PubMed ID: 21799161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate and cilostazol protect cultured rat cortical pericytes against tissue plasminogen activator (tPA)-induced cell death.
    Kim HN; Kim TY; Yoon YH; Koh JY
    Brain Res; 2015 Dec; 1628(Pt B):317-326. PubMed ID: 26111647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic neuroprotective effects of combined treatment with olmesartan plus azelnidipine in stroke-prone spontaneously hypertensive rats.
    Omote Y; Deguchi K; Kono S; Liu W; Kurata T; Hishikawa N; Yamashita T; Ikeda Y; Abe K
    J Neurosci Res; 2014 Oct; 92(10):1330-7. PubMed ID: 24839960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells.
    Zechariah A; ElAli A; Hagemann N; Jin F; Doeppner TR; Helfrich I; Mies G; Hermann DM
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1561-7. PubMed ID: 23559636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain expression of VEGF and its receptors in SHR-SP and effects of an endothelin blocker.
    Jesmin S; Sakuma I; Togashi H; Yoshioka M; Hattori Y; Kitabatake A; Miyauchi T
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S160-4. PubMed ID: 15838270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor promotes pericyte coverage of brain capillaries, improves cerebral blood flow during subsequent focal cerebral ischemia, and preserves the metabolic penumbra.
    Zechariah A; ElAli A; Doeppner TR; Jin F; Hasan MR; Helfrich I; Mies G; Hermann DM
    Stroke; 2013 Jun; 44(6):1690-7. PubMed ID: 23632977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An angiotensin II type 1 receptor blocker can preserve endothelial function and attenuate brain ischemic damage in spontaneously hypertensive rats.
    Oyama N; Yagita Y; Sasaki T; Omura-Matsuoka E; Terasaki Y; Sugiyama Y; Sakoda S; Kitagawa K
    J Neurosci Res; 2010 Oct; 88(13):2889-98. PubMed ID: 20544833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats.
    Ito H; Hashimoto A; Matsumoto Y; Yao H; Miyakoda G
    J Cereb Blood Flow Metab; 2010 Feb; 30(2):343-51. PubMed ID: 19809463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilostazol alleviates cerebral small-vessel pathology and white-matter lesions in stroke-prone spontaneously hypertensive rats.
    Fujita Y; Lin JX; Takahashi R; Tomimoto H
    Brain Res; 2008 Apr; 1203():170-6. PubMed ID: 18321473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin.
    Gelosa P; Ballerio R; Banfi C; Nobili E; Gianella A; Pignieri A; Brioschi M; Guerrini U; Castiglioni L; Blanc-Guillemaud V; Lerond L; Tremoli E; Sironi L
    J Pharmacol Exp Ther; 2010 Jul; 334(1):199-205. PubMed ID: 20332187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release.
    Ma L; Elliott SN; Cirino G; Buret A; Ignarro LJ; Wallace JL
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6470-5. PubMed ID: 11353854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of pericytes on the blood-brain barrier integrity depends critically on the pericyte differentiation stage.
    Thanabalasundaram G; Schneidewind J; Pieper C; Galla HJ
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1284-93. PubMed ID: 21601005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of telmisartan on neurovascular unit and inflammasome in stroke-resistant spontaneously hypertensive rats.
    Liu W; Yamashita T; Kurata T; Kono S; Hishikawa N; Deguchi K; Zhai Y; Abe K
    Neurol Res; 2015 Jun; 37(6):491-501. PubMed ID: 25591419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.
    Kono S; Deguchi K; Omote Y; Yunoki T; Yamashita T; Kurata T; Ikeda Y; Abe K
    J Neurosci Res; 2014 Jan; 92(1):46-53. PubMed ID: 24265137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model.
    Kasahara Y; Nakagomi T; Matsuyama T; Stern D; Taguchi A
    Stroke; 2012 Feb; 43(2):499-506. PubMed ID: 22033992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression.
    Wang H; Olszewski B; Rosebury W; Wang D; Robertson A; Keiser JA
    Biochem Biophys Res Commun; 2004 Mar; 315(2):363-8. PubMed ID: 14766216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study.
    Sakurai H; Hanyu H; Sato T; Kume K; Hirao K; Kanetaka H; Iwamoto T
    Geriatr Gerontol Int; 2013 Jan; 13(1):90-7. PubMed ID: 22672107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilostazol for primary prevention of stroke in peripheral artery disease: a population-based longitudinal study in Taiwan.
    Lee WH; Chu CY; Hsu PC; Su HM; Lin TH; Voon WC; Lai WT; Sheu SH
    Thromb Res; 2013 Aug; 132(2):190-5. PubMed ID: 23433530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.